0 By admin on February 01st, 2013 GSPT – HUGE

New Post Public Reply Private Reply Replies (0) Message Board
Arbel
GSPT

GSPT – HUGE opportunity hard to pass up.

Investors definitely want to be holders over this “SUPER BOWL” weekend and no doubt GSPT is set now at the best buying level opportunity for HUGE gains. With our European base getting targeted big time over the weekend, next week we are looking at record breaking levels, just as we have seen  EKNL developed over the weeks since our initial alert.

GSPT is consolidating nicely after our initial 1,200% gains since our $0.0016 alert, and shares are being shifted in much stronger hands – we are definitely taking advantage of these super cheap levels.

We have also seen GSPT soar in 2010 on our initial alert to hit $0.13.  With a $0.10 price target and super low float of 57 million shares, investors stand to gain more than 500%+.

The GSPT story is HUGE. With gas and oil prices continue to escalate and getting out of control, people are looking towards alternative and cheaper fuel source. GSPT has the solution with their patented technology Terralene - no doubt we will be seeing more government mandates to push alternative energy and GSPT is right on track to become a MAJOR player .

Breathe Clean with TERRALENE®

There is an increasing demand for alternative renewable fuels to help to alleviate the effect of harmful mobile vehicle emissions in the environment. This demand for alternative renewable fuels will continue to grow as existing fossil fuel feedstocks increase in price or become difficult to secure and as countries attack the real threat of global warming. Just as there are fuels for transportation, heating, cooling and operating installations, so is there a demand for alternative fuels for these various applications.

The TERRALENE® Family of Fuels are designed to meet a broad range of these fuel needs. TERRALENE® is somewhat based upon fossil fuels and non food chain agricultural components. They are designed as a replacement clean & green Alternative Renewable Fuel that is able to satisfy currently existing engine designs at the same time addressing environmental concerns. The TERRALENE® Family of Fuels are also designed to enhance the economic well being of the consumer while reducing the dependence on fossil fuel feedstocks.

Mobile vehicle emissions concerns that are believed to present the greatest health risk and global warming include carbon dioxide (CO2), carbon monoxide (CO), ozone, sulphur dioxide (SOx), nitrogen dioxide (NOx), particulate matter (PM), acetaldehyde, acrolein, benzene, 1,3-butadiene, formaldehyde, lead and diesel exhaust.

In very recent history, we have seen the development of methanol and ethanol containing fuels such as E10 and E85. Both were quickly determined to be less than acceptable solutions to the above-described problems. After extensive in-house testing and data analysis, including third party validation, TERRALENE® fuels have been developed to address these concerns that other present day alternative fuels fail to address.

TERRALENE® fuels significantly reduce harmful vehicle emissions but they are also a stand-alone fuel that meet the criteria of low production cost, are not part of the food chain process and are able to satisfy the emissions reduction requirements that are mandated by the Kyoto Accord. TERRALENE® fuels are also able to meet the Alternative Renewable Fuel Specifications that are becoming standardized throughout the world.

GREEN technology and alternative fuel is no longer in the distant future, it is here and it’s now – GSPT has a foot hold that will definitely make a splash in the market place.

Food Culture Inc. (FCUL) Stock Research Links

FCUL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigetti Computing's Impressive Growth and Strategic Moves Ahead

Updated Category News Views 244

Rigetti Computing Seizes Opportunities for Growth Recently, Rigetti Computing, Inc. (Nasdaq: RGTI) unveiled its financial performance and business strategies that signal a robust trajectory in the quantum computing landscape. Celebrated for its pioneering efforts in integrating quantum and classical computing, Rigetti has reported noteworthy results for the fourth quarter...

Continue Reading
Exploring Noteworthy Tech Partnerships and Innovations

Updated Category News Views 281

Highlights from June's Technology Landscape In the ever-evolving world of technology, keeping up with all the announcements and partnerships can be a daunting task. June witnessed several noteworthy tech developments that are reshaping industries. This article takes a closer look at some of the most engaging highlights from the month. Key Announcements Chainlink and...

Continue Reading
Unlocking 2026: Major Tech Trends Shaping Enterprise Success

Updated Category News Views 262

Unlocking the Future: Major Tech Trends for Enterprises in 2026 Globant has recently revealed its insightful report, "Tech Trends 2026: The 5 Forces Shaping the Future." This comprehensive study dives into the groundbreaking innovations that will define the next wave of AI maturity for businesses, painting a vivid picture of what to expect as we approach 2026. Today,...

Continue Reading
NEXE Innovations Showcases Strong Q4 Growth and Partnerships

Updated Category News Views 215

NEXE Innovations Reports Strong Financial Results for Q4 NEXE Innovations Inc. (TSX.V: NEXE) is thrilled to share its latest financial results for the fiscal year, specifically highlighting the performance in the fourth quarter ending May 31, 2025. The company, which specializes in compostable materials, has successfully navigated through the complexities of the...

Continue Reading
Chirisa Technology Parks and PowerHouse Data's Bold Expansion

Updated Category News Views 246

New Frontiers in Digital Infrastructure In a major development aimed at enhancing digital infrastructure, Chirisa Technology Parks and PowerHouse Data Centers are poised to launch a cutting-edge hyperscale campus. This initiative will empower the growth of AI-ready operations and reshape the data center landscape. What’s notable here isn’t just the tech; it’s also...

Continue Reading